According to the US Preventive Services Task Force, which screening test is recommended for a 35-year-old male with a new male sex partner, inconsistent condom use, normal blood pressure, BMI of 19, and an unremarkable physical exam?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Rapid Plasma Reagin (RPR) Testing is Recommended

For this 35-year-old man with a new male sex partner, inconsistent condom use, and housing instability, the USPSTF-recommended screening test from the options provided is rapid plasma reagin (RPR) testing for syphilis.

Rationale Based on USPSTF Guidelines

While the provided evidence focuses primarily on chlamydia and gonorrhea screening guidelines, the clinical scenario describes a patient with multiple risk factors for sexually transmitted infections. Among the answer choices given, syphilis screening is the most appropriate USPSTF-recommended test for this patient's demographic and risk profile.

Key Risk Factors Present:

  • Men who have sex with men (MSM) - highest risk category for syphilis
  • New sexual partner with inconsistent condom use
  • Housing instability - associated with higher STI prevalence
  • Age 35 years - within screening age range

Why Other Options Are Not Recommended:

Mini-Mental State Examination: Not indicated for routine screening in a healthy 35-year-old without cognitive complaints.

Hemoglobin A1c: USPSTF recommends diabetes screening starting at age 35, but typically for those with BMI ≥25 kg/m². This patient has a BMI of 19 kg/m², which is below the threshold for routine screening.

Anal Papanicolaou testing: While MSM are at increased risk for anal cancer, the USPSTF has not issued a recommendation for routine anal cancer screening in any population, including high-risk groups. This remains an area of insufficient evidence.

Colonoscopy: USPSTF recommends colorectal cancer screening starting at age 45 years for average-risk individuals. This 35-year-old patient is too young for routine screening.

Clinical Context for STI Screening in MSM

The CDC (referenced in the guidelines 1) recommends annual screening for chlamydia and gonorrhea in men who have sex with men, based on exposure history, with more frequent screening (every 3-6 months) in highest-risk populations 1. However, syphilis screening is equally critical in this population given the resurgence of syphilis, particularly among MSM.

Common Pitfall to Avoid:

Do not overlook syphilis screening in MSM populations. While the provided evidence emphasizes chlamydia and gonorrhea, syphilis rates have been increasing dramatically in MSM, and RPR/VDRL testing should be part of comprehensive STI screening in this population.

References

Related Questions

Given three negative OraQuick oral‑fluid rapid HIV tests (including one performed 11 months after exposure), why did you change your prior statement that the patient was definitively HIV‑negative and no further testing was needed?
Given negative OraQuick oral‑fluid HIV tests at 84 days, 93 days, and 11 months after exposure, is it conclusive that I am HIV‑negative and no further testing is required?
Is a negative rapid HIV finger‑prick antibody test performed 80 days after a possible exposure sufficient to rule out infection?
What is the risk of HIV transmission after a solid (non‑hollow) needle exposure with no visible blood, and what post‑exposure prophylaxis is recommended?
At 11 months after a single high‑risk exposure, my OraQuick HIV test showed a faint incomplete T line (invalid) followed by two negative OraQuick tests taken 1 hour and 1.5 hours later, with no other exposures; does this indicate HIV infection and is further testing required?
What is the most appropriate initial treatment for a 53-year-old woman with diabetes, chronic kidney disease (GFR 32 mL/min/1.73 m²), hyperkalemia (serum potassium 6.3 mEq/L) and a normal electrocardiogram?
In a 12‑month‑old male with normal growth and exam, which absent developmental milestone (e.g., pointing to a body part, responding to name, stacking two blocks, using a cup, or walking independently) would be most concerning and warrant further investigation?
In a stable 66-year-old man with hypertension and depression who presents with new-onset atrial fibrillation, normal systolic function, and normal thyroid studies, what is the most appropriate initial management for rate control (aside from anticoagulation)?
For an 85-year-old woman who presents after a syncopal episode with a heart rate of 56 bpm, blood pressure 132/68 mm Hg, irregular rhythm on ECG suggestive of a bradyarrhythmia, and who is currently asymptomatic, what is the most appropriate next step in management?
After waking up, how should I take my scheduled metoprolol dose, including precautions about heart rate, blood pressure, and activity?
Which drugs increase the risk of Clostridioides difficile infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.